Acid-base disturbances are very common in critically ill and injured patients as well as contribute significantly to morbidity and mortality. An understanding of the pathophysiology of these disorders is vital to their proper management. This review will discuss the etiology, pathophysiology and treatment of acid-base disturbances in intensive care patientswith particular attention to evidence from recent studies examining the effects of fluid resuscitation on acid-base and its consequences.
I N T R O D U C T I O N
The modern intensive care unit is a place where complex acidbase and electrolyte disorders are common, with one study, showing that 64% of critically ill patients have acute metabolic acidosis [1] . Although it is generally believed that most cases of acid-base derangement are mild and self-limiting, extremes of blood pH in either direction, especially when happening quickly, can have significant multiorgan consequences. Advances in evaluating acid-base balance have helped in understanding the impact of fluids in the critically ill [2] . In this review, we will discuss common causes of acid-base abnormalities in critically ill patients, and examine the evidence that these conditions result in harm to patients and briefly consider various management strategies. We will discuss these disorders using concepts from traditional and (more controversial) physical-chemical perspectives. It is our belief that these approaches are complementary not contradictory and in any case, either approach may be used successfully by the skilled practitioner.
M E TA B O L I C AC I D -B A S E D I S O R D E R S
Metabolic acidosis can arise when the concentration of organic anions (e.g. lactate or β-hydroxybutyrate) increases, when there is a loss of sodium bicarbonate (NaHCO 3 ; e.g. due to diarrhea or renal tubular acidosis) or there is a gain of exogenous anions (e.g. iatrogenic acidosis or poisonings). Metabolic alkaloses occur when there is loss of strong anions in excess of strong cations (e.g. vomiting and diuretics), or, rarely, by administration of strong cations in excess of strong anions (e.g. transfusion of large volumes of banked blood containing sodium citrate).
M E TA B O L I C AC I D O S I S
Traditionally, metabolic acidoses are categorized according to the presence or absence of unmeasured anions, inferred by calculating the anion gap (AG). The differential diagnosis for a 'positive-AG' acidosis is summarized in Table 1 . Non-AG acidoses can be divided into three types: renal, gastrointestinal and iatrogenic.
The potential effects of metabolic acidosis and alkalosis on vital organ function are presented in Table 2 . Metabolic and respiratory acidosis may have different implications with respect to survival, an observation that suggests that the underlying disorder is perhaps more important than the absolute degree of acidemia [3] . If metabolic acidemia is to be treated, consideration should be given to the likely duration of the disorder. In situations where the underlying cause is readily reversible (e.g. diabetic ketoacidosis), facilitating respiratory compensation should be considered as a first-line intervention. However, if the disorder is likely to be more chronic (e.g. renal failure), therapy aimed at restoring metabolic acid-base balance is indicated. In all cases, the therapeutic target can be estimated initially from the standard base excess (SBE). The SBE corresponds to the amount of strong acid or base that must be added in order to restore the pH to 7.4, assuming a PCO 2 of 40 mmHg. Thus, if SBE is −10 mEq/L, 10 mEq/L of strong base would need to be added (or equal amounts of strong acid removed) to return the equilibrium to normal. If one uses the physical-chemical approach [4] (our preference), this change can be viewed as a change in strong ion difference, the difference between completely dissociated anions and cations. So, for example, the plasma [Na + ] would have to increase by 10 mEq/L for NaHCO 3 administration to completely repair the acidosis. NaHCO 3 administration is associated with certain disadvantages. Large (hypertonic) doses given rapidly may lead to hypotension [5] and have the potential to cause a sudden and marked increase in Pa CO 2 [6] . Accordingly, it is important to assess the patient's ventilatory status before NaHCO 3 is administered, particularly in the absence of mechanical ventilation. NaHCO 3 infusion also affects circulating [K + ] and [Ca 2+ ], which need to be monitored closely.
Tromethamine (Tris buffer or Tham) is an organic buffer that readily penetrates cells [7] . It is a weak base ( pK 7.9); modern formulations do not alter the strong ion difference nor do they affect plasma [Na + ]. Accordingly, tromethamine is sometimes used when administration of NaHCO 3 is contraindicated because of hypernatremia. This agent has been available since the 1960s, but limited data are available on its use in humans with acid-base disorders.
A G A N D S T RO N G I O N G A P
The AG is estimated from the differences between the serum cations (Na + and K + ) and anions (Cl − and HCO À 3 ). Normally, this 'gap' is made up by albumin and, to a lesser extent, phosphate. Sulfate and lactate also contribute a small amount, normally <2 mEq/L. Plasma proteins other than albumin in the aggregate tend to be neutral, except in rare cases of abnormal paraproteins, such as multiple myeloma [8] .
In practice, the AG is calculated as follows: If the AG is increased, the explanation almost invariably will be found among five disorders: ketosis, lactic acidosis, poisoning, renal failure or sepsis [9] . However, several conditions prevalent among patients with critical illness can alter the accuracy of AG estimation [10] . Hypoalbuminemia decreases the AG and it has been recommended to 'correct' the AG by decreasing it by 2.5-3 meq/L for every 1 g/dL decrease in serum albumin concentration [11] . Respiratory and metabolic alkaloses are associated with an increase of up to 3-10 mEq/L in the apparent AG. The basis for this effect is enhanced lactate production (from stimulated phosphofructokinase enzymatic activity), reduction in the concentration of ionized weak acids (A − ) and, possibly, the additional effect of dehydration. Other factors that can increase the AG are low Mg 2+ concentration, administration of the sodium salts of poorly reabsorbable anions (such as, beta-lactam antibiotics) [12] and certain parenteral nutrition formulations, such as those containing acetate. Citrate-based anticoagulants rarely can have the same effect after multiple blood transfusions [13] . However, these rare causes do not increase the AG very much and are usually easy to identify. Additional doubt has been cast on the diagnostic value of the AG, however [10, 14] . The primary problem with the AG is its reliance on the use of a 'normal' range that depends on normal circulating levels of albumin and to a lesser extent phosphate. Plasma concentrations of albumin or phosphate are often grossly abnormal in patients with critical illness, leading to changes in the 'normal' range for the AG. Moreover, because these anions are not strong anions, their charge is affected by pH.
An alternative to the traditional AG is the strong ion gap (SIG). By definition, the strong ion difference must be equal and opposite to the negative charges contributed by [A − ] and total CO 2 . The sum of the charges from [A − ] and total CO 2 concentration has been termed 'effective strong ion difference' [15] . The 'apparent strong ion difference' is obtained by measurement of each individual ion. Both the apparent and effective strong ion differences should be equal; otherwise, unmeasured ions must exist. If the apparent strong ion difference is greater than effective strong ion difference, these ions are anions and if the apparent strong ion difference is less than the effective strong ion difference, the unmeasured ions are cations. This difference has been termed the SIG to distinguish it from the AG [16] . Unlike the AG, the SIG is normally zero and does not change with changes in pH or albumin concentration (its primary advantage over the AG). However, critical illness itself appears to result in changes in acid-base balance that alter the SIG and the AG through mechanisms not clearly identified [17] .
PO S I T I V E -A G AC I D O S E S

Lactic acidosis
Lactic acidosis is a common etiology of metabolic acidosis in the ICU [18] . Blood concentration of lactate has been shown to correlate with outcome in patients with hemorrhage [19] and sepsis [20] . Arterial blood lactate concentration reflects a balance between production and metabolism. Lactate is produced in the cytoplasm according to the following reaction:
This reaction favors lactate formation, yielding a 10-fold lactate/ pyruvate ratio, and depends on the NADH/NAD + ratio. Under physiologic conditions, lactate is mainly produced by the muscles (25%), skin (25%), brain (20%), intestine (10%) and red blood cells (20%) [21] . Traditionally, lactic acidosis has subdivided into a 'type A', in which the mechanism is thought to be tissue hypoxia, and 'type B', in which there is no hypoxia. However, this distinction is largely artificial. Some disorders, such as sepsis, may be associated with lactic acidosis due to a variety of mechanisms from inflammation to increased metabolism to decreased clearance [22] [23] [24] [25] [26] .
In shock, lactic acid was classically viewed as being produced from the musculature and the gut as a consequence of tissue hypoxia. Moreover, the proportion of lactic acid production was believed to correlate with the severity of shock as reflected by the amount of oxygen debt and magnitude of hypoperfusion. However, this view has been challenged by showing that, during endotoxemia, muscle can actually consume lactate [22] . In addition, the lungs are considered a source of lactic acid during acute lung injury [23] . Another explanation of elevated lactate has emerged that attributes elevated lactate to be due to increased metabolic activity, glycolysis and pyruvate production reflecting disease severity rather than an oxygen debt [21, 24] in addition to decreased lactate clearance in the critically ill [25, 26] . Finally, numerous drugs are associated with lactic acidosis including metformin, zidovudine and isoniazid. Administration of epinephrine may be a common cause of lactic acidosis in patients with critical illness [27] presumably by stimulating cellular metabolism (e.g. increased glycolysis in skeletal muscle).
When lactic acidosis is suspected, it is best to measure it directly. Monitoring blood pH, base deficit or AG may fail to detect hyperlactatemia as they can be affected by ventilator status, renal failure and other complex acid-base disorders [28] . A lactate-to-pyruvate ratio greater than 25:1 is considered to be evidence of anaerobic metabolism [29] . This approach makes biochemical sense, because pyruvate is reduced to lactate during anaerobic metabolism, thereby increasing the lactate-to-pyruvate ratio. Unfortunately, pyruvate is very unstable in solution and, therefore, is difficult to measure accurately in the clinical setting, greatly reducing the clinical utility of lactate/pyruvate determinations.
Treatment of lactic acidosis is generally supportive and specific therapy depends on the underlying etiology. The use of NaHCO 3 is controversial and of unproven value [30] . At best, it can be viewed as a temporizing measure. The use of renal replacement therapy (RRT) in conjunction with NaHCO 3 is likely to be more effective, but even this approach will fail if the underlying condition is not reversed. Lactate is easily removed by RRT; however, use of RRT is rarely the primary therapy.
Ketoacidosis
Ketones are formed by beta-oxidation of fatty acids, a process that is inhibited by insulin. In insulin-deficient states, ketone bodies (acetone, β-hydroxybutyrate and acetoacetate) increase substantially because elevated blood glucose concentrations promote an osmotic diuresis, leading to intravascular volume contraction. This state is associated with elevated circulating cortisol and catecholamine levels, which further stimulates free fatty acid production [31] . In addition, increased glucagon levels, relative to insulin levels, decreases intracellular concentrations of malonyl co-enzyme A and increases the activity of carnitine palmityl acyl transferase, effects that promote ketogenesis.
Ketoacidosis may result from diabetes or excessive alcohol consumption. The diagnosis is established by measuring serum ketone levels. However, it is important to understand that the nitroprusside reaction only measures acetone and acetoacetate, and not β-hydroxybutyrate. There is a risk of confusion during treatment as ketone levels, as measured by nitroprusside reaction, appear to increase as β-hydroxybutyrate is converted to acetoacetate as acidosis is clearing. Hence, it is better to monitor therapy by measuring blood pH and AG than by serum ketones.
Treatment of diabetic ketoacidosis includes infusing insulin and large amounts of fluid; 0.9% saline is usually recommended but the predictable consequence is that patients will develop hyperchloremic metabolic acidosis (see below). Potassium replacement is often required as well. This problem is further exacerbated Cl − reabsorption which increases as ketones are excreted in the urine. An increase in the tubular Na + load produces electrical-chemical forces favoring Cl − reabsorption [32] . Nevertheless, administration of NaHCO 3 is rarely necessary and should be avoided except in extreme cases [33] . Again, RRT can be used, especially if renal function is impaired, as ketones are easily removed by RRT; however the primary goal of therapy should remain focused on the underlying metabolic derangement.
Renal failure
Renal failure, especially when chronic, leads to accumulation of sulfates and other acids, widening the AG, although this increase usually is not large [34] . Similarly, uncomplicated renal failure rarely produces severe acidosis, except when accompanied by a high rate of acid generation, such as occurs with a highly catabolic state [35] . In all cases, the strong ion difference is decreased and remains so unless some therapy is provided. Hemodialysis removes sulfate and other ions and allows normal Na + and Cl − balance to be restored, thus returning the strong ion difference to normal (or near normal). However, patients not yet requiring dialysis and those who are between treatments often require some other therapy to increase the strong ion difference. NaHCO 3 can be used in caution as long as the plasma Na + concentration is not already elevated.
Other and unknown causes
Even when very careful methods are applied, using the SIG or similar strategies, unmeasured anions have been detected in the blood of patients with sepsis [36] and liver disease [37] . Furthermore, unknown cations also appear in the blood of some critically ill patients [38] . The significance of these findings remains to be determined. Various toxins that can cause metabolic acidosis are listed in Table 1 . A complete discussion of these is beyond the scope of this review.
N O N -A G ( H Y P E R C H LO R E M I C ) AC I D O S E S
Hyperchloremic metabolic acidosis occurs as a result of either the increase in [Cl
−
] relative to strong cations, especially Na + , or the loss of cations with retention of Cl − . As seen in Table 1 , these disorders can be separated by history and by measurement of urinary Cl − concentration. When acidosis occurs, the normal response by the kidney is to increase Cl − excretion. If the kidney fails to increase Cl − excretion appropriately, then impaired renal function is at least part of the problem, causing acidosis. Extrarenal causes of hyperchloremic acidosis are exogenous Cl − loads (iatrogenic acidosis) or loss of cations from the lower gastrointestinal tract without proportional losses of Cl − .
Renal tubular acidosis
Examination of the urine and plasma electrolytes and pH and calculation of the urine apparent strong ion difference allow one to correctly diagnose most cases of renal tubular acidosis [39] . However, caution must be exercised when the plasma pH is >7.35, because urinary Cl − excretion is normally decreased when pH is this high. In such circumstances, it may be necessary to infuse sodium sulfate or furosemide. These agents stimulate Cl − and K + excretion and can be used to unmask the defect and probe K + secretory capacity. Type IV renal tubular acidosis is caused by aldosterone deficiency or resistance. These disorders are diagnosed by the presence of high serum [K + ] and low urine pH (<5.5). Note that occasionally partial urinary tract obstruction may present the same way. Treatment is usually most effective if the cause can be removed; most commonly drugs such as nonsteroidal anti-inflammatory agents, heparin or potassium-sparing diuretics, are responsible. Particularly in diabetics, the condition may require management with loop diuretics in conjunction with dietary modification. Occasionally, mineralocorticoid replacement is required.
Gastrointestinal acidosis
Fluid secreted into the gut lumen contains higher amounts of Na + than Cl − . Large losses of these fluids, particularly if volume is replaced with fluids containing equal amounts of Na + and Cl − , result in a decrease in the plasma Na + concentration relative to the Cl − concentration and a decrease in strong ion difference. Such a scenario can be avoided if lactated Ringer's solution is used instead of normal saline to replace gastrointestinal losses.
Iatrogenic acidosis
Two of the most common causes of a hyperchloremic metabolic acidosis are iatrogenic and both are due to administration of Cl − . Modern parenteral nutrition formulas contain weak anions, such as acetate, in addition to Cl − . The proportions of each anion can be adjusted, depending on the acidbase status of the patient. If an insufficient amount of weak anion is provided, the plasma Cl − concentration increases and acidosis results. A similar condition can arise when saline is used for fluid resuscitation. While usually transient and of minor importance in healthy subjects, in critically ill and injured patients saline-induced acidosis is an important problem [40] .
Administration of saline causes acidosis because this solution contains equal amounts of Na + and Cl − , whereas the normal Na + concentration in plasma is 35-45 mEq/L greater than the normal Cl − concentration. Administration of 0.9% saline increases the Cl − concentration relatively more than the Na + concentration. Many critically ill patients have a significantly lower strong ion difference than do healthy individuals, even when there is no evidence of a metabolic acid-base derangement [41] . One alternative to using normal saline to resuscitate patients is to use Ringer's lactate solution. This fluid contains a more physiologic difference between [Na + ] and [Cl − ], and thus, its strong ion difference is closer to normal (28 mEq/L compared with 0 mEq/L for normal saline). Morgan et al. [42] recently showed that a solution with a strong ion difference of ∼24 mEq/L results in a neutral effect on the pH as blood is progressively diluted.
The clinical impact of iatrogenic hyperchloremic acidosis has been in debate [43] . However, mounting evidence supports the position that this adverse biochemical effect results in important adverse clinical events, especially for the kidney. Shaw et al. [44] examined the records of >30 000 patients treated with 0.9% saline for perioperative fluid management in the setting of open abdominal surgery and compared them with just under 1000 patients treated with a balanced crystalloid solution. Both overall and in a matched patient analysis, adverse effects including the use of dialysis were more frequent in the saline-treated patients. In a single-center, before-after study in Australia, Yunos et al. [45] showed that restricting the use of 'chloride-rich' solutions including saline was associated with significant reductions in the rates of acute kidney injury and use of dialysis. However, it should be noted that this was not a randomized trial and therefore susceptible to bias from secular trends.
Given this evidence, we recommend avoiding saline for fluid resuscitation, especially when large volumes required or in acidemic patients, and favor use of more balanced solutions. We recognize that lactated Ringer's solution is not ideal, given its slight hypotonicity, but the toxicity of saline appears to be a more significant concern.
M E TA B O L I C A L K A LO S I S
Metabolic alkalosis occurs as a result of an increase in strong ion difference or a decrease in A TOT . These changes can occur secondary to the loss of anions (e.g. Cl − from the stomach and albumin from the plasma) or the retention of cations (rare). Sometimes, the loss of Cl − is temporary and can be treated effectively by replacing the anion; metabolic alkalosis in this category is said to be 'chloride-responsive'. Indeed, the term 'chloride depletion' alkalosis is preferable to 'contraction' alkalosis, because chloride repletion corrects the alkalosis in the face of depleted volume but not vice versa [46] . In other cases, hormonal mechanisms produce ongoing losses of Cl − . Thus, at best, the Cl − deficit can be offset only temporarily by Cl − administration; this form of metabolic alkalosis is said to be 'chloride resistant' (Table 3) . Similar to hyperchloremic acidosis, these disorders can be distinguished by measurement of the urine Cl − concentration. Diuretics and other forms of volume contraction produce metabolic alkalosis predominantly by stimulating aldosterone secretion, as discussed earlier. However, diuretics also induce K + and Cl − excretion directly, further complicating the problem and inducing metabolic alkalosis more rapidly. Hypokalemia is also a known etiology of metabolic alkalosis [47] . Proposed mechanisms are increased H + secretion in both proximal and distal nephron, increased bicarbonate reabsorption at proximal tubule and stimulating ammoniagenesis [48] . Since hypokalemia will exacerbate metabolic acidosis, management should include repletion of potassium.
R E S P I R ATO RY AC I D -B A S E D I S O R D E R S
Respiratory disorders are easier to diagnose and treat than metabolic disorders. Normally, alveolar ventilation is adjusted to maintain Pa CO 2 between 35 and 45 mmHg. When alveolar ventilation is increased or decreased out of proportion to CO 2 production, a respiratory acid-base disorder exists.
Normal CO 2 production by the body (∼220 mL/min) is equivalent to 15 000 mM/day of carbonic acid [49] . This amount compares to <500 mM/day for all nonrespiratory acids that are handled by the kidney and gut. Pulmonary ventilation is adjusted by the respiratory center in response to changes in Pa CO 2 , blood pH and Pa O 2 as well as other factors (e.g. exercise, anxiety and wakefulness). Pa CO 2 changes in compensation for alterations in arterial pH produced by metabolic acidosis or alkalosis in predictable ways (Table 4) .
R E S P I R ATO RY AC I D O S I S
When CO 2 elimination is inadequate relative to the rate of tissue production, Pa CO 2 increases to a new steady-state determined by Primarily, compensation is accomplished by removal of Cl − from the plasma space. Since movement of Cl − into the tissues or red blood cells results in intracellular acidosis, Cl − must be removed from the body to achieve a lasting effect on the strong ion difference. The kidney is the primary organ for Cl − removal. Accordingly, patients with renal disease have a difficult time adapting to chronic respiratory acidosis. When renal function is intact, Cl − is eliminated in the urine and, after a few days, the strong ion difference increases to the level necessary to return blood pH to ∼7.35. According to the Henderson-Hasselbalch equation, the increased pH will result in an increased [HCO is not an independent variable. The primary threat to life in cases of respiratory acidosis comes not from acidosis but from hypoxemia. If the patient is breathing room air, Pa CO 2 cannot exceed 80 mmHg before life-threatening hypoxemia results. Accordingly, supplemental oxygen is always required. When the underlying cause can be addressed quickly (e.g. reversal of narcotics with naloxone), it may be possible to avoid endotracheal intubation. Mechanical support is indicated when the patient is unstable or at risk for instability or when central nervous system function deteriorates. Furthermore, in patients who are exhibiting signs of respiratory muscle fatigue, mechanical ventilation should be instituted before overt respiratory failure occurs. Thus, it is not the absolute Pa CO 2 value that is important but rather the clinical condition of the patient.
Chronic hypercapnia requires treatment when there is an acute deterioration. In this setting, it is important to recognize that the goal of therapy is not a normal value for Pa CO 2 (35-45 mmHg), but rather restoration of the patient's baseline Pa CO 2 (if known). If the baseline Pa CO 2 is not known, a target Pa CO 2 of 60 mmHg is reasonable. Overventilation has two undesirable consequences. First, life-threatening alkalemia can occur if the Pa CO 2 is rapidly normalized in a patient with chronic respiratory acidosis and an appropriately large strong ion difference. Secondly, even if the Pa CO 2 is corrected slowly, the patient will reduce the plasma strong ion difference over time, making it impossible to wean the patient from mechanical ventilation.
Noninvasive ventilation is another treatment option that is useful in selected patients, particularly those with normal sensorium [51] . Rapid infusion of NaHCO 3 in patients with respiratory acidosis can induce acute respiratory failure, if alveolar ventilation is not increased to adjust for the increased CO 2 load. Thus, if NaHCO 3 is used, it must be administered slowly and alveolar ventilation adjusted appropriately. If increasing the plasma [Na + ] is not possible or not desirable, NaHCO 3 should be avoided.
It may be useful to reduce CO 2 production by reducing the carbohydrate load in the nutritional support regimen, lowering the temperature in febrile patients and providing adequate sedation for anxious or combative patients. Treatment of shivering in the postoperative period can reduce CO 2 production. However, it is unusual to control hypercarbia with these techniques alone.
R E S P I R ATO RY A L K A LO S I S
Respiratory alkalosis may be the most frequently encountered acid-base disorder. It occurs in a number of pathologic conditions, including salicylate intoxication, early sepsis, hepatic failure and hypoxic respiratory disorders. Respiratory alkalosis also occurs with pregnancy and with pain or anxiety. Hypocapnia appears to be a particularly bad prognostic indicator in patients with critical illness [52] . As in acute respiratory acidosis, acute respiratory alkalosis results in a small change in [HCO If hypocapnia persists, the strong ion difference will begin to decrease as a result of renal Cl − reabsorption. After 2-3 days, the strong ion difference assumes a new, lower, steady state [53] . Severe alkalemia is unusual in patients with respiratory alkalosis, and management is therefore directed to the underlying cause. Typically, these mild acid-base changes are clinically more important for what they can alert the clinician to, in terms of underlying disease, than for any threat they pose to the patient. In rare cases, respiratory depression with narcotics is necessary.
P S E U D O R E S P I R ATO RY A L K A LO S I S
The presence of arterial hypocapnia in patients with profound circulatory shock has been termed 'pseudorespiratory alkalosis' [54] . This condition can be seen when alveolar ventilation is supported but the circulation is grossly inadequate. In such conditions, the mixed venous PCO 2 is significantly elevated, but the arterial PCO 2 is normal or even decreased secondary to decreased CO 2 delivery to the lungs and increased pulmonary transit time. Overall, CO 2 clearance is markedly decreased and there is marked tissue acidosis, usually involving both metabolic and respiratory components. The metabolic component comes from tissue hypoperfusion and hyperlactatemia. Arterial oxygen saturation also may appear to be adequate despite tissue hypoxemia. This condition is rapidly fatal unless cardiac output is rapidly corrected.
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